Company Analysis
Sign in

Scynexis, Inc. (SCYX)

Nasdaq: SCYX · Pharmaceutical Preparations · Jersey City, NJ · filing with the SEC since 2002
Full chart Alerts Compare
Grade5.8
◀ Past 4.4● Present 6.9▶ Future 5.7
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

18 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Scynexis, Inc.’s names, not what it holds today.

Patents granted
18
18 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
27
2 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'09'10'11'12'13'14'15'16'18'19'20'21'22'23'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals2
Organic fine chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Scynexis, Inc. its own name
US, as the owner printed on each patent
18 granted
16 published
Scynexis, Inc. its own name
named as the applicant on its applications, in US
0 granted
11 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 27, 202211,534,433Antifungal agents with enhanced activity in acidic pHPharmaceuticalsScynexis, Inc.
Sep 7, 202111,110,102Antifungal agents used in combinationPharmaceuticalsScynexis, Inc.
Feb 23, 202110,927,142Salts and polymorphs of SCY-078Organic fine chemistryScynexis, Inc.
Aug 6, 201910,370,406Salts and polymorphs of SCY-078Organic fine chemistryScynexis, Inc.
Jan 8, 201910,174,074Salts and polymorphs of SCY-078Organic fine chemistryScynexis, Inc.
Jul 28, 20159,090,671Macrocyclic peptidesPharmaceuticalsScynexis, Inc.
Mar 18, 20148,674,087Processes for isolation and purification of enfumafunginOrganic fine chemistryScynexis, Inc.
Oct 8, 20138,551,952Methods for the treatment and prevention of ocular disordersPharmaceuticalsScynexis, Inc.
Sep 17, 20138,536,114MacrocyclesPharmaceuticalsScynexis, Inc.
Dec 11, 20128,329,658Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infectionPharmaceuticalsScynexis, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Aug 7, 20252025/0248983TRITERPENOID ANTIFUNGALS FOR THE TREATMENT OF FUNGAL OSTEO-ARTICULAR INFECTIONSPharmaceuticalsScynexis, Inc.
Mar 13, 20252025/0082574INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMESPharmaceuticalsScynexis, Inc.
Nov 16, 20232023/0364067ANTIFUNGAL AGENTS WITH ENHANCED ACTIVITY IN ACIDIC PHPharmaceuticalsScynexis, Inc.
Sep 7, 20232023/0277455INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMESPharmaceuticalsScynexis, Inc.
May 18, 20232023/0149376TRITERPENOID ANTIFUNGALS FOR THE TREATMENT OR PREVENTION OF PNEUMOCYSTIS SPP. PNEUMONIAPharmaceuticalsScynexis, Inc.
Jul 7, 20222022/0211684ANTIFUNGAL AGENTS FOR CANDIDA AURIS DECOLONIZATIONPharmaceuticalsScynexis, Inc.
Jun 30, 20222022/0202833ANTIFUNGAL AGENTS USED IN COMBINATIONPharmaceuticalsScynexis, Inc.
Apr 21, 20222022/0117948TRITERPENOID ANTIFUNGALS FOR THE TREATMENT OF FUNGAL OSTEO-ARTICULAR INFECTIONSPharmaceuticalsScynexis, Inc.
Dec 23, 20212021/0395296NOVEL SALTS AND POLYMORPHS OF SCY-078Organic fine chemistryScynexis, Inc.
Dec 17, 20202020/0390751ANTIFUNGAL AGENTS WITH ENHANCED ACTIVITY IN ACIDIC PHPharmaceuticalsScynexis, Inc. · patent 11,534,433 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton SCYX · research, not advice